Abstract
Widespread dermatitis is often associated with diagnostic and therapeutic challenges. Multiple factors influence this widespread pattern of dermatitis. We aim to study the associated factors in patch-tested patients who presented with widespread pattern of dermatitis. This retrospective, case-control study was conducted on patients with dermatitis who were patch tested during January 2005 to December 2016. The demographic data, patient and family histories, diagnoses, and patch test findings were recorded and analyzed. Of the 3201 included patients, 645 (20.2%) had widespread pattern of dermatitis. Being male, age >60, and history of either atopic dermatitis (AD) or metal allergy were significantly associated with the widespread dermatitis pattern. A multivariate analysis demonstrated that preservatives were the significant offending allergens, especially methylchloroisothiazolinone/methylisothiazolinone (MCI/MI), and methylisothiazolinone (MI) alone. Widespread pattern of dermatitis is associated with gender, age, underlying atopic dermatitis and a history of metal allergy. Preservatives are the significant offending allergens of widespread dermatitis, especially MCI/MI, and MI alone. A thorough history taking and patch testin...Continue Reading
References
Jan 1, 1987·Archives of Dermatological Research·D V BelsitoR L Baer
Jun 3, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·A KatsarouS Georgala
Mar 10, 2001·The Australasian Journal of Dermatology·E Poon, J M Fewings
Apr 23, 2002·The British Journal of Dermatology·K F ThomsonB Pollock
Feb 13, 2003·Contact Dermatitis·Lin-Feng Li, Jing Wang
May 7, 2004·Contact Dermatitis·B S ModjtahediH I Maibach
Feb 21, 2006·Contact Dermatitis·Christian Stab JensenJeanne Duus Johansen
Jul 4, 2008·Journal of the American Academy of Dermatology·Kathryn A ZugFrances J Storrs
Jan 29, 2010·Acta Dermato-venereologica·Jacob P ThyssenAllan Linneberg
May 21, 2011·Journal of the American Academy of Dermatology·Erin M WarshawUNKNOWN North American Contact Dermatitis Group, 1994-2008
Nov 15, 2011·Contact Dermatitis·Waranya BoonchaiPacharee Iamtharachai
Sep 4, 2012·The Journal of Dermatology·Waranya Boonchai, Pranee Kasemsarn
Sep 22, 2012·Contact Dermatitis·Johannes GeierWolfgang Uter
Jan 24, 2013·Dermatitis : Contact, Atopic, Occupational, Drug·Mari Paz Castanedo-Tardana, Kathryn A Zug
Apr 16, 2014·Contact Dermatitis·Wisam AlwanPiu Banerjee
May 23, 2014·Contact Dermatitis·Ulrik Fischer FriisJeanne Duus Johansen
Oct 21, 2014·The Journal of Dermatology·Waranya BoonchaiPranee Kasemsarn
Dec 17, 2014·Contact Dermatitis·Jakob F SchwensenJeanne D Johansen
Mar 11, 2015·Dermatitis : Contact, Atopic, Occupational, Drug·Pailin PuangpetJohn P McFadden
Jan 23, 2016·Regulatory Toxicology and Pharmacology : RTP·UNKNOWN Scientific Committee Of Consumer Safety, A M Giménez-Arnau
Jan 23, 2016·Contact Dermatitis·Monthathip BunyavareeWaranya Boonchai
Sep 9, 2016·Dermatitis : Contact, Atopic, Occupational, Drug·Alison Spiker, Christen Mowad
Mar 25, 2017·Dermatitis : Contact, Atopic, Occupational, Drug·Marléne IsakssonMagnus Bruze
Feb 5, 2019·Expert Opinion on Drug Safety·Thomas FelixDaniela Drago
Jun 10, 2019·Regulatory Toxicology and Pharmacology : RTP· Sccs-Scientific Committee On Consumer Safety, Corrado Lodovico Galli